CD268 Antibody, anti-mouse, PE-Vio® 770, REAfinity™ 130-123-436 from Miltenyi Biotec | Biocompare.com

(1)

Citations:

Supplier Page from
Miltenyi Biotec for
CD268 Antibody, anti-mouse, PE-Vio® 770, REAfinity™

The CD268 Antibody, anti-mouse, PE-Vio® 770, REAfinity™ from Miltenyi Biotec is a Human Monoclonal antibody to TNFRSF13C. This antibody recognizes Mouse antigen. The CD268 Antibody, anti-mouse, PE-Vio® 770, REAfinity™ has been validated for the following applications: Flow Cytometry.

Product Specs
ItemCD268 Antibody, anti-mouse, PE-Vio® 770, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-123-436
Quantity30 µg in 200 µL
ApplicationsFlow cytometry
Concentration1:50
Conjugate/TagPE-Vio 770
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivitymouse
TargetCD268
IsotypeIgG1
CloneREA1217
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Nametumor necrosis factor receptor superfamily, member 13c
NCBI Gene Aliases2010006P15Rik, BAFF, BAFF-R, Baf, Baffr, Bcmd, Bcmd-1, Bcmd1, Lv, Lvis22
Clonalitymonoclonal
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1)

7/14/2022Good and Affordable Anti-Mouse CD268Dr. Andreia LinoAntibodies are produced by plasma cells (PC) that are terminally differentiated B cells and play crucial roles in host protection against infections but are considered to mediate autoimmunity in ... Read Review